Benefit administration of vitamin B1, B6, and B12 on the depression symptom in hemodialysis patients
DOI:
https://doi.org/10.22219/farmasains.v4i2.8919Keywords:
Chronic kidney disease, Depression, Vitamin BAbstract
Chronic kidney disease (CKD) is a disease that causes a decrease in kidney function, which can be seen from GFR (Glomerulus Filtration Rate) value, which is less than 60 ml/minute/1.73 m2 in minimum three months. Depression is a psychological problem in a patient with chronic kidney disease undergoing hemodialysis. The previous study has shown that giving vitamin B combination can improve depression symptoms. To measure the benefit of vitamin B1, B6, B12 parenterally for depression symptoms in chronic kidney disease patients undergoing hemodialysis. This study used an experimental design (one group pre and post-test) in 117 patient that obtained using a consecutive sampling method. Depression score was measured by the HADS questionnaire before given vitamin B (pre-test) and after given vitamin B (post-test). Data were statistically analyzed using a licensed SPSS program with paired t-test/Non-Parametric Wilcoxon. The relationship between the history of the use of the antihypertensive, antidiabetic, folic acid drug, and depression scores were not showing significant results (p > 0.05). The relationship between administration of vitamins B1, B6, and B12 and the patient's depression score showed a decrease but not significant (p = 0.522). There was no significant difference after the administration of vitamin B1, B6, and B12 on the depression score of patients with chronic kidney disease undergoing hemodialysis at Bethesda and Panti Rapih Hospital in Yogyakarta.
Downloads
References
Abraham, G., Arun, K.N., Gopalakrishnan, N., Renuka, S., Pahari, D.K., Deshpande, P., Isaac, R., Chafekar, D.S., Kher, V., Almeida, A.F., Sakhuja, V., Sundar, S., GulatiS., Abraham, A., Padmanaban, R. (2017). Management of Hypertension in Chronic Kidney Disease: Consessus Statement by an Expert Panel of Indian Nephrologists. Journal of The Association of Physicians of India.
Aisara, S., Azmi, S., Yanni, M. (2018). Gambaran Klinis Penderita Penyakit Ginjal Kronik yang Menjalani hemodialisa di RSUP Dr. M. Djamil Padang. Jurnal Kesehatan Andalas, 7(1), 42-50.
Alshogran, O.Y., Khalil, A.A., Oweis, A.O., Altawalbeh, S.M., Alqudah, M.A. (2018). Association of brain-derived neurotrophic factor and interleukin-6 serum levels with depressive and anxiety symptoms in hemodialysis patients. General Hospital Psychiatry, 53, 25–31.
Anees, M., Hameed, F., Mumtaz, A., Ibrahim, M., Khan, M.N. (2011). Dialysis-Related Factors Affecting Quality of Life in Patients on Hemodialysis. Iranian Journal of Kidney Diseases, 5(1), 9-14.
Caninsti, R. (2013). Kecemasan dan Depresi pada Pasien Gagal Ginjal Kronis yang Menjalani Terapi hemodialisa. Jurnal Psikologi Ulayat. 2 (1)
Cruz, M.C., Andrade, C., Urrutia, M., Draibe, S., Martins, L.A., Sesso, R.C. (2011). Quality of life in patients with chronic kidney disease. Clinics, 66(6),991-995.
Fauziah, Wahyono, D., Budiarti, L.E. (2015). Cost of Illness dari Chronic Kidney Disease dengan Tindakan hemodialisa. Jurnal Manajemen dan Pelayanan Farmasi, 5(3), 149-157.
Guyton, A.C. and Hall J.E. (2011). Textbook of Medical Physiology. 12th ed. Philadelphia: Elseiver.
Herbison, C.E., Hickling, S., Allen, K.L., O'Sullivan, T.A., Robinson, M., Bremner, A.P., Huang, R.C., Beilin, L.J., Mori, T.A., Oddy, W.H. (2012). Low intake of B-vitamins is associated with poor adolescent mental health and behaviour. Preventive medicine, 55(6), 634-638.
Hill, N. R., Fatoba, S. T., Oke, J. L., Hirst, J. A., O'Callaghan, C. A., Lasserson, D. S., & Hobbs, F. R. (2016). Global prevalence of chronic kidney disease-a systematic review and meta-analysis. PLoS One, 11(7), e0158765.
Ikonomou, M., Skapinakis, P., Balafa, O., Elefheroudi, M., Damigos, D., Siamopoulos, K.C. (2015). The impact of socioeconomic factors on quality of life of patients with chronic kidney disease in Greece. Journal of Renal Care, 41(4), 239–246.
Levinson, D.F. (2015). Major Depression and genetics. http://depressiongenetics.stanford.edu/mddandgenes.html. Department of Psychiatry and Behavioral Sciences.
Lin, Y.C., Chang, Y.H., Yang, S.Y., Wu, K.D., Chu, T.S. (2018). Update of pathophysiology and management of diabetic kidney disease. Journal of the Formosan Medical Association, 117, 662-675.
Mikkelsen, K., Stojanovska, L., Apostolopoulos, V. (2016). The Effects of Vitamin B in Depression. Medicinal Chemistry, 23(38), 21.
Paparrigopoulos, T., Theleritis, C. (2009). Sleep Disturbance in Haemodialysis Patient is Closely Related to Depression. General Hospital Psychiatry, 31, 175-177.
PERNEFRI. 7th Report Of Indonesian Renal Registry. (2014). http://www.indonesianrenalregistry.org. Diakses tanggal 10 September 2018.
Ritter, P.L., Ory, M.G., Laurent, D.D., Lorig, K. (2014). Effects of Chronic Disease Self-management Programs for Participants with Higher Depression Scores: Secondary Analyses of an On-line and a Small-group Program. Translational Behavioral Medicine, 4(4), 398-406.
Sibille, E. (2013). Molecular Aging of The Brain, Neuroplasticity, and Vulnerability to Depression and other Brain-related Disorders. Dialogues in Clinical Neuroscience, 15(10), 53-65.
Theofilou, P. (2011). Depression and Anxiety in Patients with Chronic Renal Failure: The Effect of Sociodemographic Characteristics. International Journal of Nephrology. Vol. 2011.
Tjang, Y.S., Pandelaki, P.A. (2018). Factors Associated with Chronic Kidney Disease Among Patients Undergoing Hemodialysis. J Indon Med Assoc, 68(4), 167-170.
United States Renal Data System. (2015). USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
Webster, A.C., Nagler, E. V., Morton, R. L., dan Masson, P. (2017). Chronic Kidney Disease. The Lancet, 389(10075), 1238.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Rizaldy Taslim Pinzon, Birgitta Lisbethiara Ardiani
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
